Coronary artery disease - drug-eluting stents
Drug-eluting stents for the treatment of coronary artery disease
Summary
Drug-eluting stents are recommended as a possible treatment for people with coronary artery disease only if: the artery to be treated is less than 3 mm in diameter or the affected section of the artery is longer than 15 mm, and the additional cost of the drug-eluting stents over bare-metal ste ...
This guidance replaces sections 1.2-1.4 of NICE technology appraisal guidance 71 (2003).
Additional funding information for this guidance can be found on the Department of Health website.
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in June 2010
About this guidance
Technology appraisals TA152
Issued: July 2008
How this guidance was produced